SULFADIAZINE+TRIMETHOPRIME/ANAFASIS (10+2)G/100G ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
SULFADIAZINE+TRIMETHOPRIME/ANAFASIS (10+2)G/100G ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Sulfadiazine
- Trimethoprim
Product identification
Medicine name:
SULFADIAZINE+TRIMETHOPRIME/ANAFASIS (10+2)G/100G ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Sulfadiazine
- Trimethoprim
Target species:
-
Cattle (calf)
-
Pig (piglet)
-
Chicken (broiler)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Sulfadiazine10.00/gram(s)100.00gram(s)
-
Trimethoprim2.00/gram(s)100.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Cattle (calf)
-
Meat and offal6day
-
-
Pig (piglet)
-
Meat and offal4day
-
-
Chicken (broiler)
-
Meat and offal3day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01EW10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 30546/14/05-06-2015/K-0210001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet